4,0
23. Sept. 2011
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Thoughtful approach to strategic efforts; struggles and often finds an acceptable balance between difficult economic re-sizing and employee cultivation; deeply committed to it vision of delivering high-quality novel medicines to patients around the world; compensation and benefits are very fair.
Kontras
Can move very slowly, either because of a post-VIOXX arrested development promoted by an over-reliance on lawyers to participate in decision making; can be too afraid of being viewed negatively, and so not take action.